References
- Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363(9413): 915–24
- Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and Clopidogrel compared with Clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364(9431): 331–7
- Rothwell PM. Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet 2004: 364(9431): 305–7
- Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324(7329): 71–86
- A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 348(9038): 1329–39
- Ringleb PA, Bhatt DL, Hirsch AT, et al; Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of Clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 2004; 35(2): 528–32
- Hankey GJ, Sudlow CL, Dunbabin DW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 2000; 31(7): 1779–84
- Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*-weighted MR1: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002; 33(6): 1536–40
- Chalela JA, Kang DW, Warach S. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging 2004; 14(1): 54–7
- Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62(4): 569–73
- Eliasziw M, Kennedy J, Hill MD, et al; North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Can Med Assoc J 2004; 170(7): 1105–9
- Yusuf S, Zhao F, Mehta SR, et al. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345(7): 494–502
- Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288(19): 2411–20 [Erratum, JAMA 2003; 289(8): 987]
- Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of Clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004; 109(12): 1476–81
- Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143(1–2): 1–13
- O'Rourke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention. Can Med Assoc J 2004; 170(7): 1123–33
- Bermudez EA, Ridker PM. C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease. Prev Cardiol 2002; 5(1): 42–6
- Kennedy J, Eliasziw M, Hill MD, et al. FASTER: clinical trial. Semin Cerebrovasc Dis Stroke 2003; 3(1): 25–30